These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Amantadine in the treatment of Creutzfeldt-Jakob disease. Braham J Arch Neurol; 1984 Jun; 41(6):585-6. PubMed ID: 6372758 [No Abstract] [Full Text] [Related]
8. Creutzfeldt-Jakob disease treated with amantidine. A report of two cases. Sanders WL; Dunn TL J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):581-4. PubMed ID: 4581346 [TBL] [Abstract][Full Text] [Related]
9. Creutzfeldt-Jakob disease with focal onset unsuccessfully treated with amantadine. Ratcliffe J; Rittman A; Wolf S; Verity MA Bull Los Angeles Neurol Soc; 1975 Jan; 40(1):18-20. PubMed ID: 1097004 [No Abstract] [Full Text] [Related]
10. [Amantadine in Creutzfeldt-Jakob disease. Review of the literature and case contribution]. Neri G; FigĂ -Talamanca L; Di Battista GC; Lo Russo F Riv Neurobiol; 1984; 30(1):47-56. PubMed ID: 6399949 [No Abstract] [Full Text] [Related]
12. Antiviral drugs in Jakob-Creutzfeldt disease. Herishanu Y J Am Geriatr Soc; 1973 May; 21(5):229-31. PubMed ID: 4575371 [No Abstract] [Full Text] [Related]
13. Experimental transmission of Creutzfeldt-Jakob disease. Tateishi J; Koga M; Mori R Acta Pathol Jpn; 1981 Nov; 31(6):943-51. PubMed ID: 7032196 [TBL] [Abstract][Full Text] [Related]
18. Antiviral chemotherapy. Med Lett Drugs Ther; 1971 Sep; 13(19):77-8. PubMed ID: 4328547 [No Abstract] [Full Text] [Related]
19. Amyloid plaques in the brains of mice with Creutzfeldt-Jakob disease. Tateishi J; Nagara H; Hikita K; Sato Y Ann Neurol; 1984 Mar; 15(3):278-80. PubMed ID: 6372648 [TBL] [Abstract][Full Text] [Related]